The Galilee Research Institute (MIGAL) spent four years creating a vaccine against the highly contagious coronavirus that infects birds called Infectious Bronchitis Virus (IBV). Now, they’re adapting the vaccine for the human coronavirus, also known as COVID-19. Read...
Read MoreThe new virus that has killed over 2,800 people is a member of the large coronavirus family of pathogens, which also includes SARS and MERS. On Thursday, the MIGAL Galilee Research Institute said in a statement a new vaccine against a coronavirus which infects chickens has brought them a step closer to developing a preparation to protect against COVID-19. Read...
Read More“Right now there is oversupply, and consumption has gone down in different markets. It’s putting a lot of pressure on the wineries and in turn the growers,” said Uri Rosenzweig, head of product at Israeli agritech start-up Trellis, uses AI to analyse data and predict production yields and harvest timing. Read...
Read MoreClimaCell, the private weather forecasting company based in Boston that has pioneered “microweather” forecasting based on sensors in smartphones, vehicles and other sources, is spinning off a nonprofit arm that will seek to close the gap in weather and climate information between developing nations and the industrialized world. Read...
Read More![[PRESS RELEASE] OurCrowd Joins Millennium Alternative Investment Network to Increase Access to Venture Capital Opportunities in United States](https://blog.mktg.ocdvlp.com/wp-content/uploads/2017/07/press_release_image.jpg)
Jerusalem / Oct. 30, 2019 – OurCrowd, the global venture investing platform and Israel’s leading venture investor, will join the Millennium Alternative Investment Network (MAIN), which provides advisors and individual investors with a streamlined way to discover, research and invest in alternative investment opportunities. Read more...
Read More
